Histamine and Bradykinin Pharmacology · Module 2
Generation comparison, individual agent profiles, and clinical selection
Generation Comparison
| Property | First Generation | Second Generation |
|---|---|---|
| Examples | Diphenhydramine, promethazine, hydroxyzine, chlorpheniramine | Loratadine, cetirizine, fexofenadine |
| CNS penetration | Yes — lipophilic, crosses blood-brain barrier readily | Minimal — less lipophilic; active P-glycoprotein efflux |
| Sedation | Prominent — limits daytime use | Minimal (fexofenadine least; cetirizine slightly more than others) |
| Antimuscarinic effects | Yes — dry mouth, urinary retention, blurred vision, constipation | None at therapeutic doses |
| Dosing frequency | Every 4–6 hours | Once daily |
| Preferred uses | Motion sickness, short-term insomnia, nighttime pruritus | Allergic rhinitis, chronic urticaria (daytime) |
Second-Generation Agent Profiles
Second Generation
Loratadine / Desloratadine
Second Generation
Cetirizine / Levocetirizine
Second Generation
Fexofenadine
First Generation — Avoid in Elderly
Diphenhydramine / Promethazine
High-Yield Rule — Anaphylaxis
Epinephrine is the only first-line treatment for anaphylaxis. Antihistamines are adjuncts that reduce pruritus and urticaria but do not reverse bronchospasm or hemodynamic collapse. No antihistamine — first- or second-generation — is ever the correct answer to "initial management of anaphylaxis."